相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Growth factors, cytokines and their receptors as downstream targets of arylhydrocarbon receptor (AhR) signaling pathways
Thomas Haarmann-Stemmann et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Intrinsic AhR function underlies cross-talk of dioxins with sex hormone signalings
Fumiaki Ohtake et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
WT1 expression distinguishes astrocytic tumor cells from normal and reactive astrocytes
Jens Schittenhelm et al.
BRAIN PATHOLOGY (2008)
The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins
Marc Veldhoen et al.
NATURE (2008)
Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor
Francisco J. Quintana et al.
NATURE (2008)
Ligand-independent regulation of transforming growth factor β1 expression and cell cycle progression by the aryl hydrocarbon receptor
Xiaoqing Chang et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
The aryl hydrocarbon receptor agonist 3,3′,4,4,5-pentachlorobiphenyl induces distinct patterns of gene expression between hepatoma and glioma cells:: Chromatin remodeling as a mechanism for selective effects
Mark S. V. Maier et al.
NEUROTOXICOLOGY (2007)
Dioxin receptor is a ligand-dependent E3 ubiquitin ligase
Fumiaki Ohtake et al.
NATURE (2007)
High TGFβ-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene
Alejandra Bruna et al.
CANCER CELL (2007)
Regulating the regulator: Factors that control levels and activity of the aryl hydrocarbon receptor
Patricia A. Harper et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Novel compound 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazo-phenyl)-amide (CH-223191) prevents 2,3,7,8-TCDD-induced toxicity by antagonizing the aryl hydrocarbon receptor
Sun-Hee Kim et al.
MOLECULAR PHARMACOLOGY (2006)
LTBP-1 blockade in dioxin receptor-null mouse embryo fibroblasts decreases TGF-β activity:: Role of extracellular proteases plasmin and elastase
A Gomez-Duran et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis
JL Marlowe et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
Similar sequence-free amplification of human glyceraldehyde-3-phosphate dehydrogenase for real time RT-PCR applications
G Carraro et al.
MOLECULAR AND CELLULAR PROBES (2005)
Integration of Smad and Forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation
J Seoane et al.
CELL (2004)
Overexpression of latent transforming growth factor-β binding protein 1 (LTBP-1) in dioxin receptor-null mouse embryo fibroblasts
B Santiago-Josefat et al.
JOURNAL OF CELL SCIENCE (2004)
The AHR-1 aryl hydrocarbon receptor and its co-factor the AHA-1 aryl hydrocarbon receptor nuclear translocator specify GABAergic neuron cell fate in C-elegans
X Huang et al.
DEVELOPMENT (2004)
Liver portal fibrosis in dioxin receptor-null mice that overexpress the latent transforming growth factor-β-binding protein-1
J Corchero et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2004)
A constitutively active dioxin/aryl hydrocarbon receptor promotes hepatocarcinogenesis in mice
O Moennikes et al.
CANCER RESEARCH (2004)
A constitutively active arylhydrocarbon receptor induces growth inhibition of Jurkat T cells through changes in the expression of genes related to apoptosis and cell cycle arrest
T Ito et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
SD-208, a novel transforming growth factor β receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo
M Uhl et al.
CANCER RESEARCH (2004)
RNA interference targeting transforming growth factor-β enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo
MA Friese et al.
CANCER RESEARCH (2004)
Genetic pathways to glioblastoma:: A population-based study
H Ohgaki et al.
CANCER RESEARCH (2004)
Modulation of oestrogen receptor signalling by association with the activated dioxin receptor
F Ohtake et al.
NATURE (2003)
Regulation of TGF-β signaling and its roles in progression of tumors
K Miyazono et al.
CANCER SCIENCE (2003)
Functional role of AhR in the expression of toxic effects by TCDD
J Mimura et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2003)
A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors
P Andersson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Definition of a dioxin receptor mutant that is a constitutive activator of transcription - Delineation of overlapping repression and ligand binding functions within the PAS domain
J McGuire et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta
W Wick et al.
JOURNAL OF NEURO-ONCOLOGY (2001)
Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice
GP Lahvis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor
Y Shimizu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)